Document is current
Any future updates will be listed below
-
Authors
Eckardt, Jan-Niklas https://orcid.org/0000-0002-3649-2823
Bornhäuser, Martin https://orcid.org/0000-0002-5916-3029
Middeke, Jan Moritz
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70117128)
- License Information
-
More Information
Article History
Received: 17 July 2026
Revised: 27 July 2026
Accepted: 12 August 2026
First Online: 19 August 2026
Ethics
Competing interests: J-NE declares consulting services for AstraZeneca, Novartis, and Johnson & Johnson, holds shares in Cancilico, has received an institutional research grant from Novartis, and has received honoraria from Amgen, Astellas, AstraZeneca, Johnson & Johnson, Novartis, Pfizer, and Servier. MB has received lecture honoraria from Jazz Pharmaceuticals and MSD and has served on advisory boards for ActiTrexx and Jazz. JMM declares consulting services for Johnson & Johnson, Roche, Gilead, AbbVie, Jazz, Pfizer, Astellas, Novartis, AstraZeneca, Clycostem, holds shares in Cancilico and Synagen, has received institutional research grants from Johnson & Johnson, Jazz and Novartis; and has received honoraria from Novartis, Roche, Johnson & Johnson, AbbVie, Pfizer, Sanofi, Astellas and Beigene.
